Type 1 Diabetes Mellitus.
Syed FZ.
Ann Intern Med. 2022 Mar;175(3):ITC33-ITC48. doi: 10.7326/AITC202203150. Epub 2022 Mar 8.
Type 1 diabetes mellitus.
Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å.
Nat Rev Dis Primers. 2017 Mar 30;3:17016. doi: 10.1038/nrdp.2017.16.
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
Zaccardi F, Webb DR, Yates T, Davies MJ.
Postgrad Med J. 2016 Feb;92(1084):63-9. doi: 10.1136/postgradmedj-2015-133281. Epub 2015 Nov 30.
Mechanisms of diabetic complications.
Forbes JM, Cooper ME.
Physiol Rev. 2013 Jan;93(1):137-88. doi: 10.1152/physrev.00045.2011.
Acute and Chronic Adverse Outcomes of Type 1 Diabetes.
Longendyke R, Grundman JB, Majidi S.
Endocrinol Metab Clin North Am. 2024 Mar;53(1):123-133. doi: 10.1016/j.ecl.2023.09.004. Epub 2023 Oct 17.
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
Yapanis M, James S, Craig ME, O'Neal D, Ekinci EI.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236. doi: 10.1210/clinem/dgac034.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R.
Lancet. 2016 Nov 5;388(10057):2254-2263. doi: 10.1016/S0140-6736(16)31535-5. Epub 2016 Sep 12.
Type 1 diabetes.
Daneman D.
Lancet. 2006 Mar 11;367(9513):847-58. doi: 10.1016/S0140-6736(06)68341-4.
Global and societal implications of the diabetes epidemic.
Zimmet P, Alberti KG, Shaw J.
Nature. 2001 Dec 13;414(6865):782-7. doi: 10.1038/414782a.
Blood immune cell profiling in adults with longstanding type 1 diabetes is associated with macrovascular complications.
He X, Wang X, van Heck J, van Cranenbroek B, van Rijssen E, Stienstra R, Netea MG, Joosten I, Tack CJ, Koenen HJPM.
Front Immunol. 2024 Jul 1;15:1401542. doi: 10.3389/fimmu.2024.1401542. eCollection 2024.
